PortfoliosLab logo
DVA vs. FMS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DVA and FMS is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

DVA vs. FMS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

DVA:

0.14

FMS:

1.40

Sortino Ratio

DVA:

0.39

FMS:

2.18

Omega Ratio

DVA:

1.05

FMS:

1.28

Calmar Ratio

DVA:

0.18

FMS:

0.71

Martin Ratio

DVA:

0.45

FMS:

6.22

Ulcer Index

DVA:

9.78%

FMS:

7.28%

Daily Std Dev

DVA:

31.42%

FMS:

28.69%

Max Drawdown

DVA:

-92.91%

FMS:

-77.28%

Current Drawdown

DVA:

-18.94%

FMS:

-42.90%

Fundamentals

Market Cap

DVA:

$11.05B

FMS:

$16.83B

EPS

DVA:

$10.72

FMS:

$1.19

PE Ratio

DVA:

13.41

FMS:

23.86

PEG Ratio

DVA:

1.97

FMS:

0.97

PS Ratio

DVA:

0.86

FMS:

0.86

PB Ratio

DVA:

91.15

FMS:

1.01

Total Revenue (TTM)

DVA:

$9.74B

FMS:

$19.49B

Gross Profit (TTM)

DVA:

$3.05B

FMS:

$4.77B

EBITDA (TTM)

DVA:

$2.12B

FMS:

$1.86B

Returns By Period

In the year-to-date period, DVA achieves a -3.87% return, which is significantly lower than FMS's 25.40% return. Over the past 10 years, DVA has outperformed FMS with an annualized return of 5.92%, while FMS has yielded a comparatively lower -2.23% annualized return.


DVA

YTD

-3.87%

1M

-6.26%

6M

-3.94%

1Y

4.54%

5Y*

12.16%

10Y*

5.92%

FMS

YTD

25.40%

1M

19.19%

6M

33.29%

1Y

34.52%

5Y*

-4.35%

10Y*

-2.23%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DVA vs. FMS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DVA
The Risk-Adjusted Performance Rank of DVA is 5454
Overall Rank
The Sharpe Ratio Rank of DVA is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of DVA is 4848
Sortino Ratio Rank
The Omega Ratio Rank of DVA is 4949
Omega Ratio Rank
The Calmar Ratio Rank of DVA is 6060
Calmar Ratio Rank
The Martin Ratio Rank of DVA is 5757
Martin Ratio Rank

FMS
The Risk-Adjusted Performance Rank of FMS is 8787
Overall Rank
The Sharpe Ratio Rank of FMS is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of FMS is 8888
Sortino Ratio Rank
The Omega Ratio Rank of FMS is 8585
Omega Ratio Rank
The Calmar Ratio Rank of FMS is 7979
Calmar Ratio Rank
The Martin Ratio Rank of FMS is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DVA vs. FMS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current DVA Sharpe Ratio is 0.14, which is lower than the FMS Sharpe Ratio of 1.40. The chart below compares the historical Sharpe Ratios of DVA and FMS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

DVA vs. FMS - Dividend Comparison

DVA has not paid dividends to shareholders, while FMS's dividend yield for the trailing twelve months is around 2.23%.


TTM20242023202220212020201920182017201620152014
DVA
DaVita Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FMS
Fresenius Medical Care AG & Co. KGaA
2.23%2.80%2.97%4.34%2.57%1.70%1.78%1.95%0.98%1.04%1.05%1.44%

Drawdowns

DVA vs. FMS - Drawdown Comparison

The maximum DVA drawdown since its inception was -92.91%, which is greater than FMS's maximum drawdown of -77.28%. Use the drawdown chart below to compare losses from any high point for DVA and FMS. For additional features, visit the drawdowns tool.


Loading data...

Volatility

DVA vs. FMS - Volatility Comparison

The current volatility for DaVita Inc. (DVA) is 8.39%, while Fresenius Medical Care AG & Co. KGaA (FMS) has a volatility of 10.35%. This indicates that DVA experiences smaller price fluctuations and is considered to be less risky than FMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

DVA vs. FMS - Financials Comparison

This section allows you to compare key financial metrics between DaVita Inc. and Fresenius Medical Care AG & Co. KGaA. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


3.00B3.50B4.00B4.50B5.00B20212022202320242025
3.29B
4.88B
(DVA) Total Revenue
(FMS) Total Revenue
Values in USD except per share items

DVA vs. FMS - Profitability Comparison

The chart below illustrates the profitability comparison between DaVita Inc. and Fresenius Medical Care AG & Co. KGaA over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

24.0%26.0%28.0%30.0%32.0%34.0%20212022202320242025
32.5%
24.3%
(DVA) Gross Margin
(FMS) Gross Margin
DVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DaVita Inc. reported a gross profit of 1.07B and revenue of 3.29B. Therefore, the gross margin over that period was 32.5%.

FMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Fresenius Medical Care AG & Co. KGaA reported a gross profit of 1.18B and revenue of 4.88B. Therefore, the gross margin over that period was 24.3%.

DVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DaVita Inc. reported an operating income of 565.36M and revenue of 3.29B, resulting in an operating margin of 17.2%.

FMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Fresenius Medical Care AG & Co. KGaA reported an operating income of 381.73M and revenue of 4.88B, resulting in an operating margin of 7.8%.

DVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DaVita Inc. reported a net income of 259.33M and revenue of 3.29B, resulting in a net margin of 7.9%.

FMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Fresenius Medical Care AG & Co. KGaA reported a net income of 151.22M and revenue of 4.88B, resulting in a net margin of 3.1%.